Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rx import bill

Executive Summary

Senate is unlikely to vote on drug importation legislation this year, Health Committee Counsel Steve Irizarry says during a Food & Drug Law Institute conference July 28. Sen. Judd Gregg (R-N.H.) postponed the markup of his bill (S 2493) due to the signing of the "BioShield" legislation (1"The Pink Sheet" July 26, 2004, In Brief). There has been speculation that Gregg delayed the markup to assess whether he had sufficient support...

You may also be interested in...

Rx import markup

Senate Health Committee's markup of Sen. Judd Gregg's (R-N.H.) drug importation bill (S 2493) will likely be delayed until September while Gregg assesses whether there is sufficient support for passage. Markup of the bill originally scheduled for July 21 was postponed because it coincided with the White House signing ceremony for the Project BioShield Act of 2004...

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.

venBio Raises $394m To Fund Biopharmas Through Human Proof-Of-Concept

Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts